Friend or foe? The elusive role of hepatic stellate cells in liver cancer

B Cogliati, CN Yashaswini, S Wang, D Sia… - Nature Reviews …, 2023 - nature.com
Liver fibrosis is a substantial risk factor for the development and progression of liver cancer,
which includes hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma …

Immune system and hepatocellular carcinoma (HCC): new insights into HCC progression

M Kotsari, V Dimopoulou, J Koskinas… - International Journal of …, 2023 - mdpi.com
According to the WHO's recently released worldwide cancer data for 2020, liver cancer
ranks sixth in morbidity and third in mortality among all malignancies. Hepatocellular …

An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte–tumor cell crosstalk, local immunosuppression and tumor progression

L Wu, J Yan, Y Bai, F Chen, X Zou, J Xu, A Huang… - Cell research, 2023 - nature.com
Dissecting and understanding the cancer ecosystem, especially that around the tumor
margins, which have strong implications for tumor cell infiltration and invasion, are essential …

FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2

M Xie, Z Lin, X Ji, X Luo, Z Zhang, M Sun, X Chen… - Journal of …, 2023 - Elsevier
Background & Aims Metastasis remains the major reason for the high mortality of patients
with hepatocellular carcinoma (HCC). This study was designed to investigate the role of E …

[HTML][HTML] Immunosuppressive CD10+ ALPL+ neutrophils promote resistance to anti-PD-1 therapy in HCC by mediating irreversible exhaustion of T cells

Y Meng, F Ye, P Nie, Q Zhao, L An, W Wang, S Qu… - Journal of …, 2023 - Elsevier
Background & Aims Remodeling the tumor microenvironment is a critical strategy for treating
advanced hepatocellular carcinoma (HCC). Yet, how distinct cell populations in the …

Gold Nanorod–mesoporous silica core shell nanocomposites for NIR-II photothermal ablation and dual PD-L1/VEGF blockade therapy in hepatocellular carcinoma

X Dai, X Li, Y Du, M Han, Z Wang, Y Wang… - Chemical Engineering …, 2023 - Elsevier
Hepatocellular carcinoma (HCC) is a common malignancy often associated with high
angiogenesis and immune suppression in the tumor microenvironment (TME). Targeting of …

Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision making

R Dhanasekaran, H Suzuki, L Lemaitre, N Kubota… - Hepatology, 2023 - journals.lww.com
Liver cancer, primarily hepatocellular carcinoma (HCC), exhibits highly heterogeneous
histological and molecular aberrations across tumors and within individual tumor nodules …

APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024

G Lau, S Obi, J Zhou, R Tateishi, S Qin, H Zhao… - Hepatology …, 2024 - Springer
Abstract In Asia–Pacific region, hepatocellular carcinoma is a serious health threat
attributing to over 600,000 deaths each year and account for over 70% of global cases …

[HTML][HTML] Detection and quantification of microplastics in various types of human tumor tissues

J Zhao, H Zhang, L Shi, Y Jia, H Sheng - Ecotoxicology and Environmental …, 2024 - Elsevier
Microplastics (MPs) have been detected in various human tissues. However, whether MPs
can accumulate within tumors and how they affect the tumor immune microenvironment …

Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis

HH Hansen, S Pors, MW Andersen, M Vyberg… - Scientific Reports, 2023 - nature.com
Non-alcoholic steatohepatitis (NASH) is emerging as a major cause of hepatocellular
carcinoma (HCC), however, it is not resolved if compounds in late-stage clinical …